Skip to main content

Continuous Crystallization: Equipment and Operation

  • Chapter
  • First Online:
Continuous Pharmaceutical Processing

Part of the book series: AAPS Advances in the Pharmaceutical Sciences Series ((AAPS,volume 42))

Abstract

Crystallization is an economical separation and purification unit operation commonly used in the pharmaceutical industry as the last drug substance manufacturing step to obtain crystalline form active pharmaceutical ingredient (API). The quality attributes of crystallization products such as purity, crystal size, crystal shape, and polymorphic form heavily influence downstream processes and may even affect the final product performance. Crystallization is one of last missing links in end-to-end continuous pharmaceutical manufacturing development because of its complex two-phase and stochastic nature. Recent advances and remaining challenges in the development of laboratorial- and industrial-scale continuous crystallization equipment, techniques, and control strategies are discussed in this chapter accompanied by a brief overview of crystallization theories as well as process analytical technology (PAT) applications in crystallization processes. The integration of continuous crystallization is also discussed in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

AFC:

Antifouling control

API:

Active pharmaceutical ingredient

ATR-FTIR:

Attenuated total reflection-Fourier transform infrared

ATR-NIR:

Attenuated total reflection-near-infrared

ATR-UV/Vis:

Attenuated total reflection-ultraviolet/visible

CFC:

Continuous filtration carousel

CFD:

Computational fluid dynamics

CIP:

Cleaning in place

COBC:

Continuous oscillatory baffled crystallizer, also known as OFBC

CSD:

Crystal size distribution

DBC:

Dynamic baffle crystallizer, also known as OBR

FBRM:

Focused beam reflectance measurement

GC:

Gas chromatography

HPLC:

High-performance liquid chromatography

MOM:

Method of moment

MS:

Mass spectrometry

MSMPR:

Mixed-suspension-mixed-product removal

MSZW:

Metastable zone width

NMR:

Nuclear magnetic resonance

OABA:

Ortho-aminobenzoic acid

OBC:

Oscillatory baffled crystallizer

OBR:

Oscillatory baffle reactor, also known as DBC

OFBC:

Oscillatory flow baffled crystallizer, also known as COBC

PAT:

Process analytical technology

PBM:

Population balance model

PFC:

Plug flow crystallizer

PSD:

Particle size distribution

PVM:

Particle vision measurement

RTD:

Residence time distribution

SASR:

Solvent-to-antisolvent ratio

SEM:

Scanning electron microscopy

STC:

Stirred tank crystallizer

UPLC:

Ultra-performance liquid chromatography

XRD:

X-ray diffraction

A :

[m2] Heat transfer area

B :

[#·s−1·m−3] Secondary nucleation rate

b :

- Secondary nucleation order

C :

[kg/m3] olution concentration

C in :

[kg/m3] Inlet solution concentration

C p :

[J·K−1·kg−1] Specific heat

D :

[m] Reactor diameter

d c :

[m] Crystal size

∆C :

[kg/m3] Absolute supersaturation

∆H c :

[J/kg] Heat of crystallization

D im :

[m] Impeller diameter

D p :

[m] Mass mean size of particles in suspension

d s :

[m] Seed size

E b :

[J/mol] Secondary nucleation temperature dependence

E g :

[J/mol] Crystal growth temperature dependence

f :

[#/m4] Population distribution of particles

f in :

[#/m4] Population distribution of particles at the inlet

G :

[m/s] Growth rate

g :

- Crystal growth order

g c :

[m/s2] Gravitational acceleration constant

h :

[W·K−1·m−2] Heat transfer coefficient

J :

[#·s−1·m−3] Primary nucleation rate

k b :

Empirical Secondary nucleation kinetic constant

k g :

Empirical Crystal growth kinetic constant

k j :

Empirical Primary nucleation kinetic constant

k v :

- Shape factor

L :

[m] Crystal characteristic length

L 0 :

[m] Nuclei size

M :

[kg/m3] Solid (magma) density

m :

Empirical Secondary nucleation solid concentration dependence

m c :

[kg] Crystal mass

m s :

[kg] Seed mass

N js :

[rad/s] Minimum rotational speed required for suspension

Q agg :

[#·s−1·m−4] Agglomeration mechanism

Q break :

[#·s−1·m−4] Breakage mechanism

i :

[m3/s] Volumetric flow rate out of the ith MSMPR

in :

[m3/s] Inlet volumetric flow rate

Q nuc :

[#·s−1·m−4] Nucleation mechanism

out :

[m3/s] Outlet volumetric flow rate

R :

[J·mol−1·K−1] Gas constant

Reo:

- Oscillatory Reynolds number

S :

- Supersaturation ratio

s :

- Relative supersaturation

St:

- Strouhal number

T :

[K] Temperature

t :

[s] Time

Tw:

[K] Heat transfer wall temperature

V :

[m3] Slurry volume

X :

- Weight percentage of solid to liquid content

x o :

[m] Oscillation amplitude

z :

[m] Length along a PFR

Z c :

Empirical Zwietering constant

δ :

[m−1] Dirac delta function at L0

μ :

[Pa·s] Viscosity

μj :

- jth moment of population distribution

ν :

[m2/s] Kinematic viscosity

ρ c :

[kg/m3] Crystal density

ρ sol :

[kg/m3] Solution density

ω :

[Hz] Oscillation frequency

References

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zoltan K. Nagy .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 American Association of Pharmaceutical Scientists

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Liu, Y.C., Nagy, Z.K. (2020). Continuous Crystallization: Equipment and Operation. In: Nagy, Z., El Hagrasy, A., Litster, J. (eds) Continuous Pharmaceutical Processing. AAPS Advances in the Pharmaceutical Sciences Series, vol 42. Springer, Cham. https://doi.org/10.1007/978-3-030-41524-2_5

Download citation

Publish with us

Policies and ethics